CORRIE FARRIS: Open Payments
NPI 1992280598 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 33 payments from 12 companies in 2025. Trend: 2023 $651 · 2024 $742 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $198 |
| ABIOMED | 1 | $150 |
| CVRx, Inc. | 2 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| Amgen Inc. | 4 | $75 |
| Kestra Medical Technology Services, Inc. | 4 | $62 |
| Alnylam Pharmaceuticals Inc. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| SCPHARMACEUTICALS INC. | 2 | $37 |
Products named: JARDIANCE, Barostim Neo System, Kerendia, LEQVIO, REPATHA, Assure WCD, AMVUTTRA, FUROSCIX.
Industry payments across IL — which companies pay providers there.
